Skandinaviska Enskilda Banken (SEB)
GMAB icon

Skandinaviska Enskilda Banken (SEB)’s Genmab GMAB Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-23,887
Closed -$494K – 829
2025
Q2 		$494K Hold
23,887
– – ﹤0.01% 705
2025
Q1 		$468K Hold
23,887
– – ﹤0.01% 700
2024
Q4 		$496K Hold
23,887
– – ﹤0.01% 712
2024
Q3 		$582K Hold
23,887
– – ﹤0.01% 708
2024
Q2 		$600K Hold
23,887
– – ﹤0.01% 678
2024
Q1 		$714K Hold
23,887
– – ﹤0.01% 684
2023
Q4 		$761K Sell
23,887
-15,977
-40% -$502K ﹤0.01% 730
2023
Q3 		$1.41M Hold
39,864
– – 0.01% 620
2023
Q2 		$1.51M Buy
39,864
+24,502
+159% +$977K 0.01% 619
2023
Q1 		$580K Sell
15,362
-435
-3% -$16.7K ﹤0.01% 759
2022
Q4 		$669K Hold
15,797
– – 0.01% 708
2022
Q3 		$508K Sell
15,797
-53,878
-77% -$1.89M ﹤0.01% 753
2022
Q2 		$2.26M Hold
69,675
– – 0.02% 541
2022
Q1 		$2.52M Hold
69,675
– – 0.01% 569
2021
Q4 		$2.78M Buy
69,675
+29,974
+75% +$1.25M 0.01% 571
2021
Q3 		$1.74M Hold
39,701
– – 0.01% 686
2021
Q2 		$1.62M Sell
39,701
-6,999
-15% -$270K 0.01% 721
2021
Q1 		$1.53M Hold
46,700
– – 0.01% 732
2020
Q4 		$1.9M Sell
46,700
-1,800
-4% -$67.3K 0.01% 668
2020
Q3 		$1.78M Sell
48,500
-13,100
-21% -$474K 0.01% 599
2020
Q2 		$2.09M Sell
61,600
-8,500
-12% -$232K 0.02% 543
2020
Q1 		$1.49M Buy
+70,100
New +$1.56M 0.02% 555

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $10.6B AUM 19.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s GMAB Position: Q3 2025 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Genmab (GMAB) in Q3 2025, closing a stake of 23,887 shares — an estimated $494K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in GMAB in Q1 2020 and held it in 22 quarters. The position peaked at $2.78M in Q4 2021. 253 funds tracked by Wall St. Rank hold GMAB as of Q3 2025.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Genmab position as of Q3 2025 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 23,887 Genmab shares in Q3 2025, an estimated $494K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Genmab in Q1 2020 and held it in 22 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Genmab position peaked at $2.78M in Q4 2021.
  • 253 funds tracked by Wall St. Rank held Genmab as of Q3 2025.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2025, filed 7 Nov 2025.